Edmond de Rothschild Holding’s Alnylam Pharmaceuticals ALNY Stock Holding History

Edmond de Rothschild Holding’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-188	Closed	-$85.7K	–	565
2025 Q3	$85.7K	Hold	188	–	–	﹤0.01%	436
2025 Q2	$61.3K	Sell	188 -130	-41%	-$36K	﹤0.01%	440
2025 Q1	$85.9K	Buy	318 +49	+18%	+$12.6K	﹤0.01%	426
2024 Q4	$63.3K	Buy	+269	New	+$70.7K	﹤0.01%	482
2024 Q3	–	Sell	-53,050	Closed	-$12.9M	–	631
2024 Q2	$12.9M	Sell	53,050 -12,000	-18%	-$1.89M	0.22%	106
2024 Q1	$9.72M	Buy	65,050 +49,250	+312%	+$8.22M	0.16%	128
2023 Q4	$3.02M	Buy	+15,800	New	+$2.69M	0.05%	202
2018 Q4	–	Sell	-208	Closed	-$18K	–	677
2018 Q3	$18K	Hold	208	–	–	﹤0.01%	679
2018 Q2	$20K	Hold	208	–	–	﹤0.01%	676
2018 Q1	$25K	Hold	208	–	–	﹤0.01%	688
2017 Q4	$26K	Hold	208	–	–	﹤0.01%	693
2017 Q3	$24K	Hold	208	–	–	﹤0.01%	718
2017 Q2	$17K	Hold	208	–	–	﹤0.01%	739
2017 Q1	$11K	Hold	208	–	–	﹤0.01%	773
2016 Q4	$8K	Hold	208	–	–	﹤0.01%	773
2016 Q3	$14K	Hold	208	–	–	﹤0.01%	771
2016 Q2	$12K	Hold	208	–	–	﹤0.01%	751
2016 Q1	$13K	Hold	208	–	–	﹤0.01%	744
2015 Q4	$20K	Hold	208	–	–	﹤0.01%	716
2015 Q3	$17K	Hold	208	–	–	﹤0.01%	731
2015 Q2	$25K	Buy	+208	New	+$24.9K	﹤0.01%	707

Other funds holding ALNY

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Edmond de Rothschild Holding's ALNY Position: Q4 2025 in Review

Edmond de Rothschild Holding sold out of Alnylam Pharmaceuticals (ALNY) in Q4 2025, closing a stake of 188 shares — an estimated $85.7K sold.

Edmond de Rothschild Holding first reported a position in ALNY in Q2 2015 and held it in 21 quarters. The position peaked at $12.9M in Q2 2024. 851 funds tracked by Wall St. Rank hold ALNY as of Q4 2025.

Edmond de Rothschild Holding reported no remaining Alnylam Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Edmond de Rothschild Holding sold 188 Alnylam Pharmaceuticals shares in Q4 2025, an estimated $85.7K.
Edmond de Rothschild Holding first reported a position in Alnylam Pharmaceuticals in Q2 2015 and held it in 21 quarters.
Edmond de Rothschild Holding's Alnylam Pharmaceuticals position peaked at $12.9M in Q2 2024.
851 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2025.

Based on Edmond de Rothschild Holding's 13F filing for Q4 2025, filed 17 Feb 2026.